Brivaracetam (Briviact) in the UK

Brivaracetam and Briviact.

Briviact is a product name for brivaracetam. Its patient leaflet describes use alongside other epilepsy medicines for partial-onset seizures, with or without spread to involve both sides of the brain.

The clinician chooses the treatment for the individual seizure history and circumstances. This guide does not rank epilepsy medicines or suggest brivaracetam for someone with new symptoms.

Epilepsy care includes an individual management plan, seizure advice and appropriate follow-up. Keep the clinical plan alongside the medicine information rather than treating the medicine name as the whole of that care.

Tablets and oral solution need different details.

Briviact has tablet and oral-solution product information. A tablet strength and a liquid concentration are different descriptions. Copy the exact form and strength from the dispensing label.

The tablet leaflet lists several strengths; the solution has its own leaflet. Those documents describe products, not what is currently available at the pharmacy. A supply question should use the actual prescribed item rather than whichever pack appears in a search result.

If the formulation is unclear or a different one has been suggested, ask the pharmacist and prescriber to check it. Do not convert a liquid dose to tablets, or tablets to a liquid, yourself.

Important points from the medicine leaflet.

The leaflet describes sleepiness, dizziness and important warnings about thoughts of self-harm. It also gives urgent instructions for serious skin reactions.

For a severe blistering or peeling rash or mouth sores, the leaflet instructs you to stop Briviact and seek medical attention immediately. Contact your doctor immediately about thoughts of self-harm; use emergency services if there is immediate danger.

Read the full leaflet for the complete precautions. Outside its urgent stop-taking instructions, do not change or stop epilepsy treatment without your clinician’s advice. Raise a supply problem before a gap occurs.

Keep all parts of the epilepsy plan visible.

Brivaracetam may be one item in a larger medicine routine. Make sure the dispensing pharmacy understands the current prescription information for each item, particularly after a clinic review or hospital discharge.

If someone else helps with medicines, agree who orders the prescription and who checks that the next supply is ready. Keep the current label and written care instructions accessible.

For practical difficulties with packaging or measuring an oral solution, ask the pharmacist for product-specific advice. The right approach depends on the prescribed form and individual needs.

When asking about an existing prescription.

Explain any item already supplied or waiting with another pharmacy. The prescription status needs checking before a second supply is arranged.

If a supply gap is becoming likely.

Contact the pharmacist and epilepsy team promptly. A supply check does not replace clinical advice about missed doses or a change in treatment.

Ask for a clear plan: which exact item is being checked, who is contacting the prescriber if needed and when you should expect an update. If the medicine is supplied through a hospital, check that team’s arrangements rather than assuming community supply.

Read the prescription-support pages for general enquiry steps and branch-checked delivery information. For urgent need, use a telephone route rather than waiting for a routine email.

Questions patients and carers ask

Related practical reading

The condition guide discusses organising existing prescriptions and questions for the clinical team.